|
Market Closed -
Canadian Securities Exchange
10:06:50 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -83.33% |
| Market Cap | 1.19M 860K 743K 698K 635K 82.27M 1.21M 8.18M 3.2M 41.2M 3.23M 3.16M 137M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 339K 293K 275K 250K 32.41M 478K 3.22M 1.26M 16.23M 1.27M 1.25M 53.94M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | +100.00% | ||
| 3 months | -33.33% | ||
| 6 months | -60.00% | ||
| Current year | -83.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0 | 0.05 | |
| 1 year | 0 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 0.75 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/2/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 3/21/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 3/21/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -80.00% | 860K | ||
| -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | ||
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | ||
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | ||
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | ||
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | ||
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | ||
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | ||
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | ||
| +0.16% | +3.87% | +16.89% | +73.73% | 172B | ||
| Average | -1.03% | +0.39% | +24.44% | +30.40% | 359.52B | |
| Weighted average by Cap. | -1.36% | +0.32% | +39.09% | +61.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.13M 2.7M 2.54M 2.31M 299M 4.41M 29.75M 11.63M 150M 11.75M 11.49M 498M | 3.36M 2.42M 2.09M 1.97M 1.79M 232M 3.42M 23.03M 9M 116M 9.09M 8.89M 385M |
| Net income | -16.5M -11.89M -10.27M -9.65M -8.78M -1.14B -16.77M -113M -44.22M -569M -44.65M -43.68M -1.89B | -8.91M -6.42M -5.55M -5.21M -4.74M -614M -9.06M -61.06M -23.87M -307M -24.11M -23.58M -1.02B |
| Net Debt | -626K -451K -389K -366K -333K -43.12M -636K -4.29M -1.68M -21.59M -1.69M -1.66M -71.75M | -723K -521K -450K -423K -385K -49.85M -735K -4.96M -1.94M -24.96M -1.96M -1.91M -82.96M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | $0.0100 | 0.00% | 100,000 |
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















